C-17 , 38th Parliament, 1st session Monday, October 4, 2004, to Tuesday, November 29, 2005
An Act to amend the Contraventions Act and the Controlled Drugs and Substances Act and to make consequential amendments to other Acts
Summary
Current status
At consideration in committee in the House of Commons
Latest activity
Referral to committee before second reading on Tuesday, November 2, 2004 (House of Commons)
Progress
House of Commons
End of stage activity
Introduction and first reading, Monday, November 1, 2004
Chamber sittings
| Sitting date | Debates (Hansard) |
|---|---|
Monday, November 1, 2004 |
End of stage activity
Referral to committee before second reading, Tuesday, November 2, 2004
Chamber sittings
| Sitting date | Debates (Hansard) |
|---|---|
Tuesday, November 2, 2004 |
Consideration in committee
No activity
Report stage and second reading
Not reached
Third reading
Not reached
First reading
Not reached
Second reading
Not reached
Third reading
Not reached
Details
Recorded votes
House of Commons
Vote 9 — Tuesday, November 2, 2004
- Result:
- Agreed To
Bill C-17, An Act to amend the Contraventions Act and the Controlled Drugs and Substances Act and to make consequential amendments to other Acts (referral to a committee before second reading)
- Yeas:
- 191
- Nays:
- 99
- Paired:
- 2
- Total:
- 292
Senate
To view the complete list of standing votes that have taken place in the Senate, please refer to the Votes page of the Senate of Canada website.Speaker's rulings and statements
There are currently no Speaker's rulings and statements.
Major speeches at second reading
There are currently no major speeches for this bill.
About
Legislative summary
A legislative summary of this bill is available from the Library of Parliament.
Similar bills
Similar bills introduced in a previous Parliament
37th Parliament, 3rd session
37th Parliament, 2nd session
From the Library of Parliament
The Library of Parliament’s research publications provide non-partisan, reliable and timely information and analysis on current and emerging issues, legislation and major public policy topics.
Further reading
A review of drug use and driving: epidemiology, impairment, risk factors and risk perceptions.
Kelly, Erin, Shane Darke and Joanne Ross.
Drug & alcohol review, 23:319-44
Canada's pot revolution.
Glass, Stephen.
Rolling stone, no. 930:79
Cannabis careers reconsidered: transitions and trajectories of committed long-term users.
Hathaway, Andrew D.
Contemporary drug problems, 31:401-23
Cannabis law reform in Canada.
Fischer, Benedikt et al..
Canadian journal of criminology and criminal justice, 45:265-97
Cannabis use in Canada : policy options for control.
Fischer, Benedict et al.
Policy options, 19:34-8
Charter rights of Canadian drug users: a constitutional assessment of the Clay trial and ruling.
Hathaway, Andrew D.
Canadian journal of law and society, 16:29-43
Conditional okay for cannabis prescription drug.
Sibbald, Barbara.
CMAJ: Canadian Medical Association journal, 172:1672
Conversations about medical marijuana between physicians and their patients.
McCarthy, Kathleen I.
Journal of legal medicine, 25:333-349
De drogue à médicament.
Sabourin, Guy.
L'Actualité pharmaceutique, 11:6-7
Entre la décriminalisation et la légalisation du cannabis : quelques réflexions d'un intervenant en toxicomanie.
Hotte, Maurice.
L'intervenant, 18:8-12
Hierarchies of harm in Canadian criminal law : the marijuana trilogy and the forcible correction of children.
Benedet, Janine.
Supreme Court law review, pp. 217-41
In harm's way: the limits to legislating criminal law.
Levine, Roslyn J.
Supreme Court law review, pp. 195-216
Inside dope.
Hardy, Quentin.
Forbes, 172:146-50, 152 ff
Joint submissions.
Rogers, Bill.
Canadian lawyer, 27:28-33
Just say maybe.
The Economist, 367:72-3
Just say yes: legalizing marijuana would actually be safer for kids than decriminalization.
Bergman, Brian.
Maclean's, 116:26-7
L'opinion de l'apothicaire sur l'usage et la légalisation du Cannabis sativa.
Dionne, Jean-Yves.
L'Actualité pharmaceutique, 11:20
La célébrité du cannabis, la décriminalisation et la prévention (2e partie).
Hotte, Maurice.
L'intervenant, 19:4-10
La célébrité du cannabis, la décriminilisation et la prévention (1re partie).
Hotte, Maurice.
L'intervenant, 19:5-10
Miracle weed.
Wilson, Clare.
New scientist, 185:38-41
New medicinal marijuana rules ease onus on physicians.
Sibbald, Barbara.
CMAJ: Canadian Medical Association journal, 173:473
Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies.
Macleod, John.
Lancet, 363:1579-88
Re-reading fundamental justice and the prohibition of marijuana.
Hern, Sean.
Criminal law quarterly, 44:487-513
Rethinking our policy on cannabis.
Boyd, Neil.
Policy options, 19:31-3
The relationship between high school marijuana use and annual earnings among young adult males.
Ringel, Jeanne A., Phyllis L. Erickson and Rebecca L. Collins.
Contemporary economic policy, 24:56-63
The Saga Continues: Canadian Legislative Attempts to Reform Cannabis Law in the Twenty-First Century.
Hyshka, Elaine.
Canadian journal of criminology & criminal justice, 51:73-91